Liver Neoplasms: all 1,406 studies
Page 13 of 15. Open to participants first (347), then studies with results posted, then the rest; newest registration first within each.
- Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver MetastasesCompletedNCT00866944Phase 2
- Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaCompletedNCT00861783Phase 1
- Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver MetastasesCompletedNCT00858429Phase 1
- Prevention of Liver Damage During Liver SurgeryStatus unknownNCT00845689Phase 1/2
- Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantCompletedNCT00844168Phase 1
- Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular CarcinomaStatus unknownNCT00842647
- Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
- Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver MassesCompletedNCT00828607
- Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib TreatmentCompletedNCT00825955Phase 3
- Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver CancerCompletedNCT00824707Not applicable
- Sonazoid Enhanced Liver Cancer Trial for Early DetectionStatus unknownNCT00822991Not applicable
- Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver CancerCompletedNCT00822562Not applicable
- Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRITerminatedNCT00820456
- Evaluation of Image-Guided Liver Surgical System for Resection of Liver CancerCompletedNCT00782886
- Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver MetastasesCompletedNCT00779272
- Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00777894Phase 1/2
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2
- The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During RadiotherapyCompletedNCT00774501Not applicable
- Genetic Analysis of Liver CancerTerminatedNCT00768001
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and CirrhosisTerminatedNCT00767468Phase 1
- Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic DissectorTerminatedNCT00763776Not applicable
- Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisCompletedNCT00743678Phase 2
- Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an OptionCompletedNCT00740753Not applicable
- Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver CancerCompletedNCT00739167
- FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal CarcinomaWithdrawnNCT00735241Phase 2/3
- Hepatic Arterial Infusion (HAI) of AbraxaneCompletedNCT00732836Phase 1
- Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACEStatus unknownNCT00730860Not applicable
- A Retrospective Review of Malignant Liver TumorsCompletedNCT00728650
- Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00728078Phase 2/3
- Treatment of Unresectable Hepatocellular Cancer With Opioid Growth FactorCompletedNCT00706576Phase 1
- Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver TumorsStatus unknownNCT00691691Phase 2
- Quality of Life After Liver ResectionCompletedNCT00681499
- Impact of Microparticles on Postoperative Complications in Surgical PatientsCompletedNCT00677781
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular CarcinomaTerminatedNCT00669136Phase 1
- Neo-adjuvant Therapy and the Effect on Synchronous Metastatic GrowthStatus unknownNCT00659022Phase 2
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver CancerCompletedNCT00652132Phase 3
- Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisStatus unknownNCT00630045Phase 3
- A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic CarcinomaCompletedNCT00629759Phase 1
- MT2004-30: Tomotherapy for Solid TumorsTerminatedNCT00623077Phase 1
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic FunctionWithdrawnNCT00605800
- Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced CancerCompletedNCT00604409Phase 1
- Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryNo longer availableNCT00589030
- Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and CharacterizationCompletedNCT00586235
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
- Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma TherapyCompletedNCT00575523Phase 4
- Phase III Study of PI-88 in Post-resection Hepatocellular CarcinomaTerminatedNCT00568308Phase 3
- Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver MetastasesCompletedNCT00557557Phase 1
- Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00557024Phase 4
- TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular CarcinomaStatus unknownNCT00556803Phase 4
- Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT00555334Phase 4
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
- Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00532740
- Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00530010
- Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver LesionsCompletedNCT00527891
- Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the LiverStatus unknownNCT00514930Phase 1/2
- Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00514228Phase 2
- Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver MetastasesWithdrawnNCT00510627Phase 4
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver MetastasesCompletedNCT00501605Phase 1
- Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver TumorsCompletedNCT00493883Phase 1/2
- Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
- Quality of Life in Patients With Liver Cancer Treated With Image-Guided TherapyCompletedNCT00482586
- National Registry and Blood Bank of Patients With Liver CancerCompletedNCT00482365
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00471484Phase 2
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00469963Not applicable
- Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00467194Phase 1
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic MetastasesCompletedNCT00465023Not applicable
- A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the LiverCompletedNCT00441376Phase 1
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- Proton Therapy and Bevacizumab for Primary Liver TumorsTerminatedNCT00426829Phase 1
- Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary TractTerminatedNCT00422877Phase 2
- Evaluation of Preoperative Investigations in Patients With Liver CancerCompletedNCT00408122
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal CancerTerminatedNCT00394992Phase 3
- Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver MetastasisCompletedNCT00392366Not applicable
- Zinc Supplements in Lowering Cadmium Levels in SmokersCompletedNCT00376987Phase 2
- Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid TumorsCompletedNCT00374660Phase 1/2
- Microarray Analysis of Gene Expression in Liver TumorsCompletedNCT00373737
- Identification of New Serum Diagnostic Markers of Hepatocellular CarcinomaCompletedNCT00373347
- Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerCompletedNCT00363584Phase 3
- SU011248 in Advanced Hepatocellular CarcinomaCompletedNCT00361309Phase 2
- HAI Via Interventionally Implanted Port Catheter SystemsStatus unknownNCT00356161Phase 2
- A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00355355Phase 3
- Genetic Susceptibility to Oncogenic VirusesCompletedNCT00341484
- Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver MetastasesCompletedNCT00327652Phase 1
- Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
- Identification of Hepatic LesionsCompletedNCT00307866Phase 3
- Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Celecoxib and Erlotinib in Treating Patients With Liver CancerWithdrawnNCT00293436Phase 1/2
- Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaStatus unknownNCT00287976Phase 2
- Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerStatus unknownNCT00276705Phase 2
- Octreotide in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00257426Phase 2
- Safety of 32P BioSilicon in Patients With Hepatocellular CarcinomaStatus unknownNCT00247260Phase 2
- Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)CompletedNCT00243633Not applicable